Vir Biotechnology, Inc. VIR
- VIR-5525 — Non-Small Cell Lung Cancer Phase 1
- VIR-5525 — Colorectal Cancer Phase 1
- VIR-5525 — Head and Neck Squamous Cell Carcinoma Phase 1
- VIR-5525 — Cutaneous Squamous Cell Carcinoma Phase 1
EGFR (4 companies · 7 programs)
Companies with an active program directed at EGFR.
Cullinan Therapeutics, Inc. CGEM
- zipalertinib — Non-Small Cell Lung Cancer NDA Submitted
Erasca, Inc. ERAS
- ERAS-12 Preclinical
Janux Therapeutics, Inc. JANX
- JANX008 Phase 1